A Phase 3 Randomized, Open-label, Active-comparator Controlled ClinicalStudy of Pembrolizumab versus Platinum Doublet Chemotherapy in Participants WithMismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in theFirst-line Settin

Project: Research project

Project Details

Description

A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Settin
StatusActive
Effective start/end date11/2/21 → 11/30/26

Funding

  • THE GOG FOUNDATION, INC
  • MERCK, SHARP & DOHME LLC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint